Surgery Partners, Inc.: income tax expense or benefit
Income tax expense or benefit for Surgery Partners, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Surgery Partners, Inc. financial histories
What this measure means
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
Exact concept: us-gaap:IncomeTaxExpenseBenefit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 18,000,000 | USD | 2026-03-02 | 10-K · 0001638833-26-000008 |
| 2024-01-01 | 2024-12-31 | 134,600,000 | USD | 2026-03-02 | 10-K · 0001638833-26-000008 |
| 2023-01-01 | 2023-12-31 | -300,000 | USD | 2026-03-02 | 10-K · 0001638833-26-000008 |
| 2022-01-01 | 2022-12-31 | 23,300,000 | USD | 2025-03-07 | 10-K · 0001638833-25-000053 |
| 2021-01-01 | 2021-12-31 | 10,500,000 | USD | 2024-02-26 | 10-K · 0001638833-24-000029 |
| 2020-01-01 | 2020-12-31 | -20,100,000 | USD | 2023-03-01 | 10-K · 0001638833-23-000021 |
| 2019-01-01 | 2019-12-31 | 9,500,000 | USD | 2022-03-01 | 10-K · 0001638833-22-000019 |
| 2018-01-01 | 2018-12-31 | 26,400,000 | USD | 2021-03-10 | 10-K · 0001638833-21-000034 |
| 2016-01-01 | 2016-12-31 | 7,095,000 | USD | 2017-03-10 | 10-K · 0001638833-17-000007 |
| 2015-01-01 | 2015-12-31 | -148,982,000 | USD | 2017-03-10 | 10-K · 0001638833-17-000007 |
| 2014-01-01 | 2014-12-31 | 15,758,000 | USD | 2017-03-10 | 10-K · 0001638833-17-000007 |
| 2013-01-01 | 2013-12-31 | 7,570,000 | USD | 2016-03-11 | 10-K · 0001638833-16-000019 |
Related financial histories
- Surgery Partners, Inc.: total assets
- Surgery Partners, Inc.: stockholders equity
- Surgery Partners, Inc.: cash and cash equivalents
- Surgery Partners, Inc.: net income or loss
- Surgery Partners, Inc.: operating cash flow
- Surgery Partners, Inc.: capital expenditure payments
- Surgery Partners, Inc.: revenue
- Surgery Partners, Inc.: financing cash flow
- Surgery Partners, Inc.: investing cash flow
- Surgery Partners, Inc.: retained earnings or deficit
- Surgery Partners, Inc.: basic weighted-average shares
- Surgery Partners, Inc.: diluted weighted-average shares
- Surgery Partners, Inc.: basic earnings per share
- Surgery Partners, Inc.: diluted earnings per share
- Surgery Partners, Inc.: share-based compensation expense
- Surgery Partners, Inc.: operating income or loss
- Surgery Partners, Inc.: current assets
- Surgery Partners, Inc.: current liabilities
- Surgery Partners, Inc.: current accounts payable
- Surgery Partners, Inc.: goodwill carrying amount
- Surgery Partners, Inc.: net finite-lived intangible assets
- Surgery Partners, Inc.: net current accounts receivable
- Surgery Partners, Inc.: common-stock repurchase payments
- Surgery Partners, Inc.: operating expenses
- Surgery Partners, Inc.: net inventory
- Surgery Partners, Inc.: cost of revenue
Inspect the source
- Entity
- Surgery Partners, Inc. / CIK 0001638833
- Captured
- 2026-09-21T17:21:30.121Z
- SEC response SHA-256
bc373cda2831e595fe4e979ac98c961e92460892866b7f8672af64ad3a9b4ac8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001638833.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))